Companies: 49,245 Total Market Cap: 132632662887577.49

Dawnrays Pharmaceutical (Holdings) Limited

HKG-2348
Healthcare Drug Manufacturers - Specialty & Generic
Rank #19017
Market Cap 224.40 M
Volume 144,000
Price 0.15
Change (%) 0.85%
Country or region Hong Kong Hong Kong

Dawnrays Pharmaceutical (Holdings) Limited's latest marketcap:

224.40 M

As of 05/20/2025, Dawnrays Pharmaceutical (Holdings) Limited's market capitalization has reached $224.40 M. According to our data, Dawnrays Pharmaceutical (Holdings) Limited is the 19017th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 224.40 M
Revenue (ttm) 144.07 M
Net Income (ttm) 76.76 M
Shares Out 1.50 B
EPS (ttm) 0.05
Forward PE 0.00
Ex-Dividend Date 05/27/2025
Earnings Date 05/23/2025
Market Cap Chart
Data Updated: 05/20/2025

Dawnrays Pharmaceutical (Holdings) Limited's yearly market capitalization.

Dawnrays Pharmaceutical (Holdings) Limited has seen its market value drop from HK$2.11 B to HK$1.76 B since 2020, representing a total decrease of 16.58% and an annual compound decline rate (CAGR) of 4.05%.
Date Market Cap Change (%)
05/20/2025 HK$1.76 B -4.9%
12/31/2024 HK$1.83 B 16.32%
12/29/2023 HK$1.58 B -20.97%
12/30/2022 HK$1.99 B -20.34%
12/31/2021 HK$2.50 B 18.77%
12/31/2020 HK$2.11 B

Company Profile

About Dawnrays Pharmaceutical (Holdings) Limited

Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company specializing in the development, manufacturing, and sale of non-patented pharmaceutical medicines. The company operates primarily in Mainland China and internationally.

Business Segments

The company operates through two key segments:

  • Intermediates and Bulk Medicines
  • Finished Drugs

Product Offerings

Dawnrays Pharmaceutical provides a diverse range of pharmaceutical products, including:

  • Antibiotics: Pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics.
  • System-Specific Medicines:
    • Cardiovascular systems
    • Anti-allergic, anti-HBV, and digestive systems
    • Urinary systems
    • Anti-pyretic analgesic, respiratory, and endocrine system drugs

These products are available in various forms, including tablets, capsules, and granules.

Company Background

Founded in 1995, Dawnrays Pharmaceutical (Holdings) Limited is headquartered in Wan Chai, Hong Kong.

Frequently Asked Questions

As of 05/20/2025, Dawnrays Pharmaceutical (Holdings) Limited (including the parent company, if applicable) has an estimated market capitalization of $224.40 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Dawnrays Pharmaceutical (Holdings) Limited global market capitalization ranking is approximately 19017 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Hong Kong
Founded 1995
IPO Date n/a
Employees 1,183
CEO Liwei Yu
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Address CNT Tower
Wan Chai
Hong Kong
Website https://www.dawnrays.com
People Also Watch
Zoetis
163.94 0.85%
Merck KGaA
129.99 0.85%
Haleon plc
545.72 0.85%
NSE-SUNPHARMA
19.90 0.85%